Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1655
This examiner grants 47% of resolved cases
Michael V Meller manages 760 resolved cases in Art Unit 1655. The examiner has an allowance rate of 47.1% and a median days to allowance of 1181. The interview lift is 28.2%, suggesting that interviews are a helpful tool for applicants in Tech Center 1600. This 28.2% lift is a notable statistic for the 760 resolved cases in this profile and indicates that verbal discussion can effectively bridge gaps in understanding.
The 47.1% allowance rate suggests a moderate level of difficulty, making the 28.2% interview lift a critical component of a successful strategy. The 1181-day median pendency is a standard duration for reaching a grant in this art unit. Practitioners should utilize interviews to resolve complex technical or legal issues, as the examiner appears receptive to such interactions. With a large volume of 760 resolved cases, these metrics are highly reliable indicators of the examiner's typical prosecution style. A balanced approach of strong written responses and strategic interviews is likely to yield the best results.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18271769 | SYNERGISTIC MIXTURES COMPRISING PYRETHRUM FOR ARTHROPOD TOXICITY AND REPELLENCY | Final Rejection | University of Florida Research Foundation, Incorporated |
| 17836823 | ORAL COMPOSITIONS WITH REDUCED WATER CONTENT | Non-Final OA | NICOVENTURES TRADING LIMITED |
| 18441653 | COMPOSITION FOR PREVENTING OR TREATING LIVER FIBROSIS INCLUDING SANGUISORBA OFFICINALIS EXTRACT AS ACTIVE INGREDIENT | Non-Final OA | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY |
| 18551393 | METHODS OF USING COMPOSITIONS COMPRISING AN ICELAND MOSS EXTRACT | Non-Final OA | Kenvue Brands LLC |
| 18724284 | SEED TREATMENT METHODS FOR INCREASING YIELD IN CROP PLANTS | Non-Final OA | BAYER AKTIENGESELLSCHAFT |
| 17792348 | KIDNEY REGENERATION ACCELERATOR AND PRODUCTION METHOD FOR SAME | Non-Final OA | JSR Corporation |
| 18900504 | COMPOSITIONS AND METHODS FOR PREVENTING AND RECOVERY FROM DETRIMENTAL EFFECTS OF ALCOHOL CONSUMPTION | Non-Final OA | Cheers Health, Inc. |
| 18900420 | COMPOSITIONS AND METHODS FOR PREVENTING AND RECOVERY FROM DETRIMENTAL EFFECTS OF ALCOHOL CONSUMPTION | Non-Final OA | Cheers Health, Inc. |
| 18466003 | METHOD FOR TREATING AND/OR PREVENTING EDEMATOUS FIBROSCLEROTIC PANNICULOPATHY | Final Rejection | CALIWAY BIOPHARMACEUTICALS CO., LTD. |
| 18475303 | PHENOL DERIVATIVE-MODIFIED, TISSUE-DERIVED EXTRACELLULAR MATRIX DERIVATIVE FOR CONSTRUCTION OF ARTIFICIAL TISSUE | Final Rejection | CELLARTGEN INC. |
| 17847975 | HIGH FIBER NUTRITIONAL COMPOSITIONS WITH IMPROVED ORGANOLEPTIC CHARACTERISTICS FOR BETTER DIET MANAGEMENT | Non-Final OA | HAGE BT GLOBAL, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy